Article Sidebar

PDF
Date Published: 21/06/2024
Abstract Views: 57
Views PDF: 43
DOI: https://doi.org/10.56535/jmpm.v49i5.663
Issue
Vol. 49 No. 5 (2024): TẠP CHÍ Y DƯỢC HỌC QUÂN SỰ SỐ 5 - 2024
Section
Articles
How to Cite
Vũ, H. H., Nguyễn, V. T., & Lương, V. N. (2024). KHẢO SÁT MỘT SỐ YẾU TỐ NGUY CƠ CÓ THỂ PHÒNG NGỪA, GIẢM GÁNH NẶNG TRÊN BỆNH NHÂN RUNG NHĨ. Journal of Military Pharmaco-medicine, 49(5), 155-163. https://doi.org/10.56535/jmpm.v49i5.663

KHẢO SÁT MỘT SỐ YẾU TỐ NGUY CƠ CÓ THỂ PHÒNG NGỪA, GIẢM GÁNH NẶNG TRÊN BỆNH NHÂN RUNG NHĨ

Học Huấn Vũ1, , Văn Tình Nguyễn2, Văn Nam Lương1
1 Bệnh viện Đa khoa Quốc tế Hải Phòng
2 Bệnh viện Phụ sản Trung ương

Main Article Content

Abstract

Objective: Assess the situation of some risk factors that can be prevented, reduce the burden on the group of patients with atrial fibrillation at Hai Phong International Hospital. Study method: A retrospective study of 60 atrial fibrillation outpatients at Hai Phong International General Hospital from October 2023 to December 2023. Results: 45.0% of patients with BMI ≥ 23; 10.0% with lipid metabolism disorders and 8.3% with diabetes mellitus. 71.7% of all cases had a combination of heart failure; 13.3% without heart valvular disease but CHA2DS2-VASc scores recorded ≥ 2. Conclusion: Groups of patients with high BMI, with metabolic disorders need improvement planning, monitoring and treatment. All patients without heart valve diseases are eligible for recommended anticoagulants.

Article Details

Keywords

atrial fibrillation, heart failure, stroke

References

1. Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, Shah N, Chothani A, Savani GT, Mehta K, Parikh V, Rathod A, Badheka AO, Lafferty J, Kowalski M, Mehta JL, Mitrani RD, Viles-Gonzalez JF, Paydak H. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: Implications for healthcare planning. Circulation. 2014; 129:2371-2379.
2. Link MS, Haïssaguerre M, Natale A. Ablation of atrial fibrillation: Patient selection, periprocedural anticoagulation, techniques, and preventive measures after ablation. Circulation. 2016; 134:339-352.
3. Malmo V, Nes BM, Amundsen BH, Tjonna AE, Stoylen A, Rossvoll O, Wisloff U, Loennechen JP. Aerobic interval training reduces the burden of atrial fibrillation in the short term: A randomized trial. Circulation. 2016; 133:466-473.
4. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest. 2010 Feb; 137(2):263-272.
5. Zathar Z, Karunatilleke A, Fawzy AM, Lip GYH. Atrial Fibrillation in Older People: Concepts and Controversies. Front Med (Lausanne). 2019 Aug 8; 6:175.
6. Lee YS, Yang PS, Jang E, Kim D, Yu HT, Kim TH, Uhm JS, Sung JH, Pak HN, Lee MH, Joung B. Association between Obesity and heart failure and related atrial fibrillation: Patient-level data comparisons of two cohort studies. Yonsei Med J. 2024 Jan; 65(1):10-18.
7. Lancini D, Sun J, Mylonas G, Boots R, Atherton J, Prasad S, Martin P. Predictors of new onset atrial fibrillation burden in the critically ill. Cardiology. 2023 Oct 7.
8. Chamberlain, A. M. et al. Metabolic syndrome and incidence of atrial fbrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 2010; 159:850-856.
9. J Gumprecht, G Y H Lip, A Sokal, B Sredniawa, J Stokwiszewski, T Zdrojewski, T Grodzicki, J Kazmierczak, G Opolski, Z Kalarus, Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the NOMED-AF prospective cross-sectional observational study. European Heart Journal. November 2023; 44(2): ehad655.448.
10. lrabadi N, Al-Nusair M, El-Zubi FK, Tashtoush M, Alzoubi O, Khamis S, Masadeh MM, Alzoubi KH, Al-Hiari M, Hammoudeh A. Evaluation of clinical, echocardiographic, and therapeutic characteristics, and prognostic outcomes of coexisting heart failure among patients with atrial fibrillation: The Jordan Atrial Fibrillation (JoFib) study. Curr Vasc Pharmacol. 2023 Nov 30.